HCA Healthcare (NYSE:HCA) Price Target Cut to $260.00

HCA Healthcare (NYSE:HCAGet Rating) had its target price decreased by research analysts at Credit Suisse Group from $296.00 to $260.00 in a report released on Monday, The Fly reports. Credit Suisse Group’s price target would indicate a potential upside of 23.43% from the stock’s current price.

Several other research analysts have also recently weighed in on HCA. Wells Fargo & Company started coverage on HCA Healthcare in a research report on Monday, March 28th. They set an “equal weight” rating and a $267.00 price objective for the company. Truist Financial upped their target price on HCA Healthcare from $290.00 to $310.00 and gave the stock a “buy” rating in a report on Wednesday, January 5th. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, April 6th. SVB Leerink reduced their price target on HCA Healthcare from $320.00 to $304.00 and set an “outperform” rating on the stock in a research report on Friday, January 28th. Finally, TheStreet upgraded HCA Healthcare from a “c+” rating to a “b-” rating in a research note on Monday, March 21st. Eight equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of $277.65.

HCA Healthcare stock opened at $210.64 on Monday. The company has a debt-to-equity ratio of 23.06, a current ratio of 1.41 and a quick ratio of 1.21. The company has a market capitalization of $63.62 billion, a PE ratio of 9.91, a price-to-earnings-growth ratio of 1.48 and a beta of 1.60. HCA Healthcare has a one year low of $196.22 and a one year high of $279.02. The business has a 50 day simple moving average of $256.53 and a 200 day simple moving average of $248.92.

HCA Healthcare (NYSE:HCAGet Rating) last posted its earnings results on Friday, April 22nd. The company reported $4.12 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $4.25 by ($0.13). HCA Healthcare had a return on equity of 303.35% and a net margin of 11.84%. The company had revenue of $14.95 billion for the quarter, compared to the consensus estimate of $14.72 billion. During the same quarter last year, the business earned $4.14 EPS. HCA Healthcare’s quarterly revenue was up 6.9% compared to the same quarter last year. Equities analysts anticipate that HCA Healthcare will post 18.74 earnings per share for the current fiscal year.

HCA Healthcare announced that its Board of Directors has authorized a share buyback program on Thursday, January 27th that allows the company to repurchase $8.00 billion in outstanding shares. This repurchase authorization allows the company to buy up to 10.9% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s board believes its shares are undervalued.

In other HCA Healthcare news, SVP Joseph A. Sowell III sold 11,522 shares of the stock in a transaction that occurred on Friday, March 11th. The shares were sold at an average price of $269.00, for a total value of $3,099,418.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider A Bruce Moore, Jr. sold 20,633 shares of the company’s stock in a transaction on Wednesday, February 16th. The stock was sold at an average price of $244.01, for a total transaction of $5,034,658.33. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by corporate insiders.

Several large investors have recently bought and sold shares of the company. Transform Wealth LLC increased its holdings in shares of HCA Healthcare by 6.5% during the 1st quarter. Transform Wealth LLC now owns 17,950 shares of the company’s stock valued at $4,499,000 after purchasing an additional 1,095 shares in the last quarter. Peak Financial Advisors LLC purchased a new position in shares of HCA Healthcare during the 1st quarter valued at approximately $1,240,000. Allworth Financial LP increased its holdings in shares of HCA Healthcare by 15.9% during the 1st quarter. Allworth Financial LP now owns 589 shares of the company’s stock valued at $148,000 after purchasing an additional 81 shares in the last quarter. Truist Financial Corp increased its holdings in HCA Healthcare by 13.3% in the 1st quarter. Truist Financial Corp now owns 611,214 shares of the company’s stock worth $153,182,000 after acquiring an additional 71,559 shares in the last quarter. Finally, Wright Investors Service Inc. purchased a new stake in HCA Healthcare in the 1st quarter worth $961,000. 66.36% of the stock is owned by hedge funds and other institutional investors.

About HCA Healthcare (Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Stories

The Fly logo

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.